Kodiak Sciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KOD and other ETFs, options, and stocks.About KOD
Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD.
CEOVictor Perlroth
CEOVictor Perlroth
Employees109
Employees109
HeadquartersPalo Alto, California
HeadquartersPalo Alto, California
Founded2009
Founded2009
Employees109
Employees109
KOD Key Statistics
Market cap222.40M
Market cap222.40M
Price-Earnings ratio-1.17
Price-Earnings ratio-1.17
Dividend yield—
Dividend yield—
Average volume332.21K
Average volume332.21K
High today$4.43
High today$4.43
Low today$4.19
Low today$4.19
Open price$4.22
Open price$4.22
Volume299.14K
Volume299.14K
52 Week high$11.60
52 Week high$11.60
52 Week low$1.92
52 Week low$1.92
KOD News
Simply Wall St 6d
Talkspace And 2 Other Compelling Penny Stocks To ConsiderOver the last 7 days, the market has risen 1.4%, and in the past year, it has climbed 12%, with earnings forecasted to grow by 15% annually. In such a climate,...
People also own
Based on the portfolios of people who own KOD. This list is generated using Robinhood data, and it’s not a recommendation.